Baxter Oncology GmbH (manufacturer of unpackaged products, primary packaging and quality control)

The drug is used to prevent premature ovulation in women during controlled ovarian stimulation when subsequent oocyte retrieval and the use of assisted reproductive technologies are planned.

Dosage form: powder and solvent for injection solution

ATC: H01CC02